个性化文献订阅>期刊> ACS Medicinal Chemistry Letters
 

Discovery of AMG 369, a Thiazolo[5,4-b]pyridine Agonist of S1P(1) and S1P(5)

  作者 CEE VICTOR J; FROHN MIKE; LANMAN BRIAN A; GOLDEN JENNIFER; MULLER KRISTINE; NEIRA SUSANA; PICKRELL ALEX; ARNETT HEATHER; BUYS JANET; GORE ANU; FIORINO MIKE; HORNER MICHELLE; ITANO ANDREA; LEE MATT R; MCELVAIN MICHELE; MIDDLETON SCOT; SCHRAG MICHAEL; RIVENZONSEGAL DALIA; VARGAS HUGO M; XU HAN; XU YANG; ZHANG XUXIA; SIU JERRY; WONG MIN; BUERLI ROLAND W  
  选自 期刊  ACS Medicinal Chemistry Letters;  卷期  2011年2-2;  页码  107-112  
  关联知识点  
 

[摘要]The optimization of a series of thiazolopyridine S1P(1) agonists with limited activity, at the S1P(3) receptor is reported. These efforts resulted in the discovery of 1-(3-fluoro-4-(5-(1-phenylcycloprol)thiazolo[5,4-b]pyridin-2yl)benzyl)-a zetidine-3-carboxylic acid (5d, AMG 369), a potent dual S1P(1)/S1P(5) agonist with limited activity at S1P(3) and no activity at S1P(2)/S1P(4). Dosed orally at 0.1 mg/kg, 5d is shown to reduce blood lymphocyte counts 24 h postdose and delay the onset and reduce the severity of experimental autoimmune encephalomyelitis in rat.

 
      被申请数(0)  
 

[全文传递流程]

一般上传文献全文的时限在1个工作日内